Unexplained resolution of diagnosed hypogonadism
- PMID: 26982515
- DOI: 10.1097/j.pain.0000000000000468
Unexplained resolution of diagnosed hypogonadism
Comment in
-
Reply.Pain. 2016 Apr;157(4):990-991. doi: 10.1097/j.pain.0000000000000467. Pain. 2016. PMID: 26982516 No abstract available.
Comment on
-
Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial.Pain. 2015 Feb;156(2):280-288. doi: 10.1097/01.j.pain.0000460308.86819.aa. Pain. 2015. PMID: 25599449 Free PMC article. Clinical Trial.
References
-
- Barnhart JW, Caldwell WJ. Gas chromatographic determination of hydrocodone in serum. J Chromatogr 1977;130:243–9.
-
- Basaria S, Thomas G, Travison TG. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized-controlled trial. PAIN 2015;156:280–8.
-
- Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536–59.
-
- McRae AL, Sonne SC. Opioid equivalency: a review. J Pharm Prac 1998;11:394–404.
-
- Otton SV, Schadel M, Cheung SW, Kaplan HL, Busto UE, Sellers EM. CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone. Clin Pharmacol Ther 1993;54:463–72.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
